InspireMD Inc. (NSPR)

May 23, 2026

InspireMD (NSPR) Q1 2026 Earnings: EPS Beat Despite Net Loss, Shares Dip 2.9%Post-Announcement Reaction - Newser

May 23, 2026

May 22, 2026

Paul Stuka to Retire from InspireMD Board, Will Not Seek Re‑election - TradingView

May 22, 2026

May 22, 2026

InspireMD (NSPR) chair Paul Stuka plans Board retirement in 2027 - Stock Titan

May 22, 2026

May 22, 2026

NSPR Technical Analysis | Trend, Signals & Chart Patterns | INSPIREMD INC (NASDAQ:NSPR) - ChartMill

May 22, 2026

May 22, 2026

NSPR Q1 2026 Earnings: Loss Narrower Than Expected as InspireMD Advances Commercial PipelineProfit Growth Outlook - Newser

May 22, 2026

May 21, 2026

InspireMD CCO Shane Gleason sells $189,594 in stock By Investing.com - Investing.com Australia

May 21, 2026

May 21, 2026

InspireMD CCO Shane Gleason sells $189,594 in stock - Investing.com

May 21, 2026

May 21, 2026

InspireMD (NSPR) CCO auto-sells shares to cover RSU tax obligations - Stock Titan

May 21, 2026

May 17, 2026

InspireMD (NSPR) price target decreased by 13.33% to 4.42 - MSN

May 17, 2026

May 15, 2026

Nantahala reports 4.82M shares in InspireMD (NSPR) including convertibles - Stock Titan

May 15, 2026

May 15, 2026

Director Stuka increases InspireMD (NSPR) stake with 15,000-share buys - Stock Titan

May 15, 2026

May 15, 2026

Velan Capital holds 4.99% of InspireMD (NASDAQ: NSPR) via 2.35M shares - Stock Titan

May 15, 2026

May 14, 2026

InspireMD CEO Marvin Slosman buys $25,200 in company stock By Investing.com - Investing.com Australia

May 14, 2026

May 13, 2026

InspireMD Inc (NSPR) CEO Marvin Slosman Increases Stake with Rec - GuruFocus

May 13, 2026

May 13, 2026

NSPR: Endovascular stenting for carotid disease is accelerating, backed by best-in-class clinical results - TradingView

May 13, 2026

May 13, 2026

InspireMD CEO Marvin Slosman buys $25,200 in company stock - Investing.com UK

May 13, 2026

May 13, 2026

InspireMD (NSPR) CEO adds 21,000 shares in $1.20 open-market buy - Stock Titan

May 13, 2026

May 13, 2026

InspireMD (NSPR) director boosts stake with 75,626-share buy, corrects 10b5-1 and ownership details - Stock Titan

May 13, 2026

May 12, 2026

InspireMD director Paul Stuka buys $88,026 in shares - Investing.com UK

May 12, 2026

May 12, 2026

InspireMD director Paul Stuka buys $88,026 in shares By Investing.com - Investing.com South Africa

May 12, 2026

May 12, 2026

InspireMD (NSPR) director Paul Stuka adds 75,626 shares in open-market buys - Stock Titan

May 12, 2026

May 10, 2026

InspireMD Balances Fast Growth With U.S. Setback - TipRanks

May 10, 2026

May 10, 2026

MSN Money - MSN

May 10, 2026

May 09, 2026

InspireMD (NSPR) Q2 2025 Earnings Transcript - AOL.com

May 09, 2026

May 09, 2026

InspireMD (NSPR) Q3 2025 Earnings Transcript - AOL.com

May 09, 2026

May 08, 2026

Insider Buying: InspireMD (NYSE:NSPR) Director Acquires 15,995 Shares of Stock - MarketBeat

May 08, 2026

May 08, 2026

Insider Buying: InspireMD (NYSE:NSPR) Director Acquires 73,255 Shares of Stock - MarketBeat

May 08, 2026

May 08, 2026

InspireMD director Ward R. buys $102,637 in company stock By Investing.com - Investing.com Australia

May 08, 2026

May 08, 2026

InspireMD director Ward R. buys $102,637 in company stock - Investing.com India

May 08, 2026

May 08, 2026

InspireMD director Gary Roubin buys $106,200 in company stock - Investing.com UK

May 08, 2026

May 08, 2026

[Form 4] InspireMD, Inc. Insider Trading Activity - Stock Titan

May 08, 2026

May 08, 2026

InspireMD director Gary Roubin buys $106,200 in company stock By Investing.com - Investing.com Nigeria

May 08, 2026

May 08, 2026

Gary Roubin Buys 90,000 Shares of InspireMD (NYSE:NSPR) Stock - MarketBeat

May 08, 2026

May 08, 2026

Director Paul Stuka adds 7,895 InspireMD (NSPR) shares in open‑market buys - Stock Titan

May 08, 2026

May 08, 2026

Why InspireMD (NSPR) ability to execute stands out (Underperforming) 2026-05-08Long Setup - newser.com

May 08, 2026